Kanhaiya Singh, Indiana University, Purdue University Indianapolis, United States Updates Copyright 2022 de Frana, dos Santos, Baptista, Da Silva, Fukushima, Hirota, Martins and Caperuto
During pregnancy If the patient, dermatologist, GP and other members of the care team make a shared decision that the patient will remain on biologic therapy during pregnancy, TNF inhibitors are advised for use due to more data availability with these therapies during pregnancy (67), and/or the prescribing information of additional therapies should be consulted
Many non-diabetics are now using GLP-1 agonists because they work fast
Proper refrigeration ensures you receive the full therapeutic benefit with each injection